/Investor DB

Smilegate Investment — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Kai Healthkaihealth.aiinFeb 2024

Kai Health builds technology to systematically prevent preventable medical errors, offering an Autonomous Performance Improvement platform aimed at helping health systems reduce liability, recover revenue, and drive continuous improvement.

AI & Machine LearningDigital HealthHealthtechSaaS

Hallie Woods Kosena(Chief Executive Officer, Accessum Health)

Co-investorsDistributed VenturesNFPIMM InvestmentSBVATranslink Investment

MarqVisionmarqvision.comin𝕏Series B · Oct 2024

MarqVision provides brand protection and intellectual property management services using AI technology for creators, developers, and artists globally.

AdTechAI & Machine LearningEnterprise SoftwareMarketing TechSaaSLos Angeles, US

Mark Lee(CEO)inMark I. Lee ⚡(Founder)inDK Lee(Founder)DK (Do Kyung) LeeVinny MeiKik Lee(Sales)

Co-investorsAtinum Investment Co. Ltd.Coral CapitalHillspring InvestmentHongShan Capital GroupPeak XV PartnersSalesforce Ventures+7 more

Medintechmedintech.co.krinMay 2024

MedinTech develops motorized flexible endoscopes built on AI and robotics, offering precise, lightweight operation and AI-based procedure assistance for physicians.

AI & Machine LearningMedical DevicesRobotics

Myungjoon Kim 님(Founder)in

Co-investorsAtinum Investment Co. Ltd.FuturePlayHana VenturesIndustrial Bank of KoreaNextrans

Reclrecl.co.krApr 2024

Platform for collection, resale, and reuse of second-hand apparel

Co-investorsBig Basin CapitalThe Ventures Co

블리몽키즈velymonkeys.comin𝕏Aug 2024

Vely Monkeys (블리몽키즈) operates a retail platform that helps Korean beauty (K-beauty) brands enter the Indian market, connecting some 1,300 vetted brands from listing through local distribution via a proprietary AI system.

AI & Machine LearningE-commerceMarketplacesSeoul, KR

Co-investorsLaguna InvestmentSchmidtCompany K PartnersMashup VenturesQuad Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.